Annual D&A
$3.01 M
+$112.00 K+3.87%
31 December 2023
Summary:
Celldex Therapeutics annual depreciation & amortization is currently $3.01 million, with the most recent change of +$112.00 thousand (+3.87%) on 31 December 2023. During the last 3 years, it has fallen by -$921.00 thousand (-23.44%). CLDX annual D&A is now -48.68% below its all-time high of $5.86 million, reached on 31 December 2010.CLDX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$786.00 K
-$11.00 K-1.38%
01 September 2024
Summary:
Celldex Therapeutics quarterly depreciation & amortization is currently $786.00 thousand, with the most recent change of -$11.00 thousand (-1.38%) on 01 September 2024. Over the past year, it has increased by +$19.00 thousand (+2.48%). CLDX quarterly D&A is now -67.63% below its all-time high of $2.43 million, reached on 31 March 2010.CLDX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$3.12 M
+$19.00 K+0.61%
01 September 2024
Summary:
Celldex Therapeutics TTM depreciation & amortization is currently $3.12 million, with the most recent change of +$19.00 thousand (+0.61%) on 01 September 2024. Over the past year, it has increased by +$195.00 thousand (+6.67%). CLDX TTM D&A is now -49.23% below its all-time high of $6.14 million, reached on 30 September 2010.CLDX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +2.5% | +6.7% |
| 3 y3 years | -23.4% | +4.5% | +2.3% |
| 5 y5 years | -20.9% | -34.9% | -29.7% |
CLDX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.4% | +3.9% | -3.1% | +17.1% | at high | +10.9% |
| 5 y | 5 years | -38.1% | +3.9% | -34.9% | +17.1% | -35.8% | +10.9% |
| alltime | all time | -48.7% | +652.0% | -67.6% | +227.0% | -49.2% | >+9999.0% |
Celldex Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $786.00 K(-1.4%) | $3.12 M(+0.6%) |
| June 2024 | - | $797.00 K(+2.8%) | $3.10 M(+1.3%) |
| Mar 2024 | - | $775.00 K(+2.1%) | $3.06 M(+1.6%) |
| Dec 2023 | $3.01 M(+3.9%) | $759.00 K(-1.0%) | $3.01 M(+2.9%) |
| Sept 2023 | - | $767.00 K(+1.5%) | $2.92 M(+3.4%) |
| June 2023 | - | $756.00 K(+4.1%) | $2.83 M(+0.5%) |
| Mar 2023 | - | $726.00 K(+7.9%) | $2.81 M(-2.9%) |
| Dec 2022 | $2.90 M(-5.6%) | $673.00 K(+0.3%) | $2.90 M(-3.5%) |
| Sept 2022 | - | $671.00 K(-9.4%) | $3.00 M(-2.6%) |
| June 2022 | - | $741.00 K(-8.6%) | $3.08 M(-0.7%) |
| Mar 2022 | - | $811.00 K(+4.4%) | $3.10 M(+1.2%) |
| Dec 2021 | $3.07 M(-21.9%) | $777.00 K(+3.3%) | $3.07 M(+0.7%) |
| Sept 2021 | - | $752.00 K(-1.6%) | $3.05 M(-3.5%) |
| June 2021 | - | $764.00 K(-1.4%) | $3.15 M(-10.9%) |
| Mar 2021 | - | $775.00 K(+2.6%) | $3.54 M(-9.9%) |
| Dec 2020 | $3.93 M(-19.1%) | $755.00 K(-12.3%) | $3.93 M(-9.0%) |
| Sept 2020 | - | $861.00 K(-25.0%) | $4.32 M(-7.4%) |
| June 2020 | - | $1.15 M(-1.5%) | $4.67 M(-0.1%) |
| Mar 2020 | - | $1.17 M(+1.7%) | $4.67 M(-3.8%) |
| Dec 2019 | $4.86 M(+27.8%) | $1.15 M(-5.2%) | $4.86 M(+9.6%) |
| Sept 2019 | - | $1.21 M(+4.8%) | $4.43 M(+9.2%) |
| June 2019 | - | $1.15 M(-14.7%) | $4.06 M(+4.1%) |
| Mar 2019 | - | $1.35 M(+87.5%) | $3.90 M(+2.6%) |
| Dec 2018 | $3.80 M(-28.4%) | $721.00 K(-13.7%) | $3.80 M(-12.1%) |
| Sept 2018 | - | $835.00 K(-15.9%) | $4.33 M(-8.7%) |
| June 2018 | - | $993.00 K(-20.7%) | $4.74 M(-4.7%) |
| Mar 2018 | - | $1.25 M(+0.5%) | $4.97 M(-6.4%) |
| Dec 2017 | $5.31 M(+29.8%) | $1.25 M(-0.2%) | $5.31 M(+0.9%) |
| Sept 2017 | - | $1.25 M(+2.0%) | $5.26 M(+5.9%) |
| June 2017 | - | $1.23 M(-23.0%) | $4.97 M(+6.0%) |
| Mar 2017 | - | $1.59 M(+32.8%) | $4.69 M(+14.5%) |
| Dec 2016 | $4.09 M(+2.0%) | $1.20 M(+25.5%) | $4.09 M(+2.4%) |
| Sept 2016 | - | $954.00 K(+0.8%) | $4.00 M(-1.6%) |
| June 2016 | - | $946.00 K(-4.9%) | $4.06 M(-0.5%) |
| Mar 2016 | - | $995.00 K(-9.5%) | $4.08 M(+1.7%) |
| Dec 2015 | $4.01 M(+17.9%) | $1.10 M(+7.8%) | $4.01 M(+5.9%) |
| Sept 2015 | - | $1.02 M(+5.6%) | $3.79 M(+4.5%) |
| June 2015 | - | $966.00 K(+4.4%) | $3.62 M(+3.7%) |
| Mar 2015 | - | $925.00 K(+5.5%) | $3.49 M(+2.7%) |
| Dec 2014 | $3.40 M(+15.5%) | $877.00 K(+2.5%) | $3.40 M(+3.5%) |
| Sept 2014 | - | $856.00 K(+2.4%) | $3.29 M(+3.9%) |
| June 2014 | - | $836.00 K(+0.5%) | $3.16 M(+3.5%) |
| Mar 2014 | - | $832.00 K(+9.0%) | $3.06 M(+3.8%) |
| Dec 2013 | $2.94 M(-6.1%) | $763.00 K(+4.2%) | $2.94 M(+1.3%) |
| Sept 2013 | - | $732.00 K(+0.4%) | $2.91 M(-0.8%) |
| June 2013 | - | $729.00 K(+1.1%) | $2.93 M(-3.0%) |
| Mar 2013 | - | $721.00 K(-0.6%) | $3.02 M(-3.6%) |
| Dec 2012 | $3.14 M(-24.6%) | $725.00 K(-4.1%) | $3.14 M(-3.6%) |
| Sept 2012 | - | $756.00 K(-7.9%) | $3.25 M(-12.5%) |
| June 2012 | - | $821.00 K(-1.7%) | $3.72 M(-5.8%) |
| Mar 2012 | - | $835.00 K(-0.9%) | $3.95 M(-5.0%) |
| Dec 2011 | $4.16 M(-29.0%) | $843.00 K(-31.0%) | $4.16 M(-3.9%) |
| Sept 2011 | - | $1.22 M(+16.3%) | $4.33 M(+3.8%) |
| June 2011 | - | $1.05 M(+0.6%) | $4.17 M(-6.9%) |
| Mar 2011 | - | $1.04 M(+3.2%) | $4.48 M(-23.6%) |
| Dec 2010 | $5.86 M(+65.9%) | $1.01 M(-4.6%) | $5.86 M(-4.5%) |
| Sept 2010 | - | $1.06 M(-21.8%) | $6.14 M(+6.0%) |
| June 2010 | - | $1.36 M(-44.1%) | $5.79 M(+11.8%) |
| Mar 2010 | - | $2.43 M(+88.1%) | $5.18 M(+46.6%) |
| Dec 2009 | $3.53 M(+39.2%) | $1.29 M(+80.8%) | $3.53 M(+28.4%) |
| Sept 2009 | - | $714.00 K(-4.3%) | $2.75 M(-3.5%) |
| June 2009 | - | $746.00 K(-4.5%) | $2.85 M(-2.3%) |
| Mar 2009 | - | $781.00 K(+53.3%) | $2.92 M(+14.9%) |
| Dec 2008 | $2.54 M(+206.7%) | $509.40 K(-37.4%) | $2.54 M(+14.1%) |
| Sept 2008 | - | $813.40 K(+0.2%) | $2.22 M(+176.0%) |
| June 2008 | - | $812.10 K(+102.0%) | $805.40 K(-21.0%) |
| Mar 2008 | - | $402.00 K(+105.7%) | $1.02 M(+23.3%) |
| Dec 2007 | $827.10 K | $195.40 K(-132.3%) | $827.10 K(+6464.3%) |
| Sept 2007 | - | -$604.10 K(-158.8%) | $12.60 K(-98.9%) |
| June 2007 | - | $1.03 M(+391.0%) | $1.16 M(+86.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $209.10 K(-133.8%) | $622.50 K(-29.8%) |
| Dec 2006 | $886.50 K(-58.4%) | -$619.10 K(-214.2%) | $886.50 K(-58.4%) |
| Sept 2006 | - | $542.30 K(+10.6%) | $2.13 M(-1.6%) |
| June 2006 | - | $490.20 K(+3.6%) | $2.16 M(-4.3%) |
| Mar 2006 | - | $473.10 K(-24.2%) | $2.26 M(+6.1%) |
| Dec 2005 | $2.13 M(+24.1%) | $624.00 K(+8.3%) | $2.13 M(+8.1%) |
| Sept 2005 | - | $576.40 K(-1.8%) | $1.97 M(+8.9%) |
| June 2005 | - | $586.90 K(+71.4%) | $1.81 M(+10.5%) |
| Mar 2005 | - | $342.40 K(-26.2%) | $1.64 M(-4.6%) |
| Dec 2004 | $1.72 M(+12.4%) | $464.10 K(+11.6%) | $1.72 M(+19.2%) |
| Sept 2004 | - | $416.00 K(+0.4%) | $1.44 M(-2.3%) |
| June 2004 | - | $414.40 K(-1.7%) | $1.47 M(-2.7%) |
| Mar 2004 | - | $421.70 K(+125.1%) | $1.51 M(-0.9%) |
| Dec 2003 | $1.53 M(-5.9%) | $187.30 K(-58.4%) | $1.53 M(-12.0%) |
| Sept 2003 | - | $449.80 K(-1.1%) | $1.73 M(+3.1%) |
| June 2003 | - | $454.90 K(+4.6%) | $1.68 M(+3.3%) |
| Mar 2003 | - | $435.10 K(+10.2%) | $1.63 M(+0.4%) |
| Dec 2002 | $1.62 M(-28.1%) | $394.80 K(-0.5%) | $1.62 M(-11.4%) |
| Sept 2002 | - | $396.90 K(-1.0%) | $1.83 M(-7.4%) |
| June 2002 | - | $401.10 K(-6.6%) | $1.98 M(-7.8%) |
| Mar 2002 | - | $429.30 K(-28.8%) | $2.14 M(-5.1%) |
| Dec 2001 | $2.26 M(+72.2%) | $603.00 K(+11.2%) | $2.26 M(+10.4%) |
| Sept 2001 | - | $542.20 K(-4.5%) | $2.05 M(+13.5%) |
| June 2001 | - | $567.70 K(+4.3%) | $1.80 M(+17.6%) |
| Mar 2001 | - | $544.40 K(+39.2%) | $1.53 M(+16.9%) |
| Dec 2000 | $1.31 M(-34.1%) | $391.00 K(+31.0%) | $1.31 M(+8.5%) |
| Sept 2000 | - | $298.50 K(-0.1%) | $1.21 M(-20.0%) |
| June 2000 | - | $298.70 K(-7.4%) | $1.51 M(-11.8%) |
| Mar 2000 | - | $322.60 K(+11.8%) | $1.71 M(-13.9%) |
| Dec 1999 | $1.99 M(+98.9%) | $288.60 K(-51.9%) | $1.99 M(-13.5%) |
| Sept 1999 | - | $600.00 K(+20.0%) | $2.30 M(+21.1%) |
| June 1999 | - | $500.00 K(-16.7%) | $1.90 M(+26.7%) |
| Mar 1999 | - | $600.00 K(0.0%) | $1.50 M(+50.0%) |
| Dec 1998 | $1.00 M(+150.0%) | $600.00 K(+200.0%) | $1.00 M(+100.0%) |
| Sept 1998 | - | $200.00 K(+100.0%) | $500.00 K(+25.0%) |
| June 1998 | - | $100.00 K(0.0%) | $400.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $400.00 K(0.0%) |
| Dec 1997 | $400.00 K(-20.0%) | $100.00 K(0.0%) | $400.00 K(0.0%) |
| Sept 1997 | - | $100.00 K(0.0%) | $400.00 K(-20.0%) |
| June 1997 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Dec 1996 | $500.00 K(-28.6%) | $100.00 K(-50.0%) | $500.00 K(-28.6%) |
| Sept 1996 | - | $200.00 K(+100.0%) | $700.00 K(+16.7%) |
| June 1996 | - | $100.00 K(0.0%) | $600.00 K(0.0%) |
| Mar 1996 | - | $100.00 K(-66.7%) | $600.00 K(-14.3%) |
| Dec 1995 | $700.00 K(-12.5%) | $300.00 K(+200.0%) | $700.00 K(+16.7%) |
| Sept 1995 | - | $100.00 K(0.0%) | $600.00 K(-14.3%) |
| June 1995 | - | $100.00 K(-50.0%) | $700.00 K(-12.5%) |
| Mar 1995 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Dec 1994 | $800.00 K(-11.1%) | $200.00 K(0.0%) | $800.00 K(-20.0%) |
| Sept 1994 | - | $200.00 K(0.0%) | $1.00 M(0.0%) |
| June 1994 | - | $200.00 K(0.0%) | $1.00 M(+11.1%) |
| Mar 1994 | - | $200.00 K(-50.0%) | $900.00 K(0.0%) |
| Dec 1993 | $900.00 K(+50.0%) | $400.00 K(+100.0%) | $900.00 K(+80.0%) |
| Sept 1993 | - | $200.00 K(+100.0%) | $500.00 K(-16.7%) |
| June 1993 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Mar 1993 | - | $200.00 K(-33.3%) | $600.00 K(-14.3%) |
| Dec 1992 | $600.00 K(0.0%) | - | - |
| Oct 1992 | - | $300.00 K(+200.0%) | $700.00 K(+16.7%) |
| July 1992 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Apr 1992 | - | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| Apr 1992 | $600.00 K(0.0%) | - | - |
| Jan 1992 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Oct 1991 | - | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| July 1991 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Apr 1991 | $600.00 K(+20.0%) | $200.00 K(+100.0%) | $600.00 K(+50.0%) |
| Jan 1991 | - | $100.00 K(-50.0%) | $400.00 K(+33.3%) |
| Oct 1990 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| July 1990 | - | $100.00 K | $100.00 K |
| Apr 1990 | $500.00 K | - | - |
FAQ
- What is Celldex Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Celldex Therapeutics?
- What is Celldex Therapeutics annual D&A year-on-year change?
- What is Celldex Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly D&A year-on-year change?
- What is Celldex Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Celldex Therapeutics?
- What is Celldex Therapeutics TTM D&A year-on-year change?
What is Celldex Therapeutics annual depreciation & amortization?
The current annual D&A of CLDX is $3.01 M
What is the all time high annual D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high annual depreciation & amortization is $5.86 M
What is Celldex Therapeutics annual D&A year-on-year change?
Over the past year, CLDX annual depreciation & amortization has changed by +$112.00 K (+3.87%)
What is Celldex Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CLDX is $786.00 K
What is the all time high quarterly D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly depreciation & amortization is $2.43 M
What is Celldex Therapeutics quarterly D&A year-on-year change?
Over the past year, CLDX quarterly depreciation & amortization has changed by +$19.00 K (+2.48%)
What is Celldex Therapeutics TTM depreciation & amortization?
The current TTM D&A of CLDX is $3.12 M
What is the all time high TTM D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM depreciation & amortization is $6.14 M
What is Celldex Therapeutics TTM D&A year-on-year change?
Over the past year, CLDX TTM depreciation & amortization has changed by +$195.00 K (+6.67%)